Diabetes Research and Clinical Practice
Volume 86, Issue 3 , Pages 177-185 , December 2009

Intra-renal hemodynamics and carotid intima-media thickness in the metabolic syndrome

  • Silvio Buscemi

      Affiliations

    • Department of Internal Medicine, Cardiovascular and Kidney Diseases, University of Palermo, Italy
    • Corresponding Author InformationCorresponding author at: Dipartimento di Medicina Interna, Malattie Cardiovascolari e NefroUrologiche, University of Palermo – Policlinico “P. Giaccone”, Via del Vespro, 129, I-90127 Palermo, Italy. Tel.: +39 091 6554580; fax: +39 091 6552144.
    • ,
  • Salvatore Verga

      Affiliations

    • Department of Internal Medicine, Cardiovascular and Kidney Diseases, University of Palermo, Italy
    • ,
  • John A. Batsis

      Affiliations

    • Section of General Internal Medicine, Department of Medicine, Dartmouth-Hitchcock Medical Center, Lebanon, NH, United States
    • ,
  • Santina Cottone

      Affiliations

    • Department of Internal Medicine, Cardiovascular and Kidney Diseases, University of Palermo, Italy
    • ,
  • Alessandro Mattina

      Affiliations

    • Department of Internal Medicine, Cardiovascular and Kidney Diseases, University of Palermo, Italy
    • ,
  • Andrea Re

      Affiliations

    • Department of Internal Medicine, Cardiovascular and Kidney Diseases, University of Palermo, Italy
    • ,
  • Mariangela Arnone

      Affiliations

    • Department of Internal Medicine, Cardiovascular and Kidney Diseases, University of Palermo, Italy
    • ,
  • Salvatore Citarda

      Affiliations

    • Department of Internal Medicine, Cardiovascular and Kidney Diseases, University of Palermo, Italy
    • ,
  • Giovanni Cerasola

      Affiliations

    • Department of Internal Medicine, Cardiovascular and Kidney Diseases, University of Palermo, Italy

Received 6 May 2009 ,Revised 5 September 2009 ,Accepted 15 September 2009.

References 

  1. Gami AS, Witt BJ, Howard DE, Erwin PJ, Gami LA, Somers VK, et al. Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies. JACC. 2007;49:403–414
  2. Batsis JA, Nieto-Martinez RE, Lopez-Jimenez F. Metabolic syndrome: from global epidemiology to individualized medicine. Clin. Pharmacol. Ther. 2007;82:509–524
  3. Grimble E. Inflammatory status and insulin resistance. Curr. Opin. Clin. Nutr. 2002;5:551–559
  4. Bertoni AG, Wong ND, Shea S, Ma S, Liu K, Preethi S, et al. Insulin resistance, metabolic syndrome, and subclinical atherosclerosis. Diabetes Care. 2007;30:2951–2956
  5. Hu FB, Stampfer MJ, Haffner SM, Solomon CG, Willett WC, Manson JE. Elevated risk of cardiovascular disease prior to clinical diagnosis of type 2 diabetes. Diabetes Care. 2002;25:1129–1134
  6. Djaberi R, Beishuizen ED, Pereira AM, Rabelink TJ, Smit JW, Tamsma JT, et al. Non-invasive cardiac imaging techniques and vascular tools for the assessment of cardiovascular disease in type 2 diabetes mellitus. Diabetologia. 2008;51:1581–1593
  7. O’Leary DH, Polak JF, Kronmal RA, Manolio TA, Burke GL, Wolfson SK. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research group. N. Engl. J. Med. 1999;340:14–22
  8. Petersen LJ, Petersen JR, Ladefoged SD, Mehlsen J, Jensen HA. The pulsatility index and the resistive index in renal arteries in patients with hypertension and chronic renal failure. Nephrol. Dial. Transplant. 1995;10:2060–2064
  9. Okura T, Watanabe S, Miyoshi K, Fukuoka T, Higaki J. Intrarenal and carotid hemodynamics in patients with essential hypertension. Am. J. Hypertens. 2004;17:240–244
  10. Derchi LE, Leoncini G, Parodi D, Viazzi F, Martinoli C, Ratto E, et al. Mild renal dysfunction and renal vascular resistance in primary hypertension. Am. J. Hypertens. 2004;18:966–971
  11. Mather KJ, Lteif A, Steinberg HO, Baron AD. Interactions between endothelin and nitric oxide in the regulation of vascular tone in obesity and diabetes. Diabetes. 2004;53:2060–2066
  12. Su TC, Lee YT, Chou S, Hwang WT, Chen CF, Wang JD. Twenty-four-hour ambulatory blood pressure and duration of hypertension as major determinants for intima-media thickness and atherosclerosis of carotid arteries. Atherosclerosis. 2006;184:151–156
  13. Brohall G, Odén A, Fagerberg B. Carotid artery intima-media thickness in patients with type 2 diabetes mellitus and impaired glucose tolerance: a systematic review. Diabet. Med. 2005;23:609–616
  14. Kotsis VT, Stabouli SV, Papamichael CM, Zakopoulos NA. Impact of obesity in intima media thickness of carotid arteries. Obesity. 2006;14:1708–1715
  15. Bots ML, Hoes AW, Koudstaal PJ, Hofman A, Grobbee DE. Common carotid intima-media thickness and risk of stroke and myocardial infarction: the Rotterdam study. Circulation. 1997;96:1432–1437
  16. Mostbeck GH, Kain R, Mallek R, Derfler K, Walter R, Havelec L, et al. Duplex Doppler sonography in renal parenchymal disease. Histopathologic correlation. J. Ultrasound Med. 1991;10:190–194
  17. Johnson RJ, Herrera-Acosta J, Schreiner GF, Rodriguez-Iturbe B. Subtle acquired renal injury as a mechanism of salt-sensitive hypertension. N. Engl. J. Med. 2002;346:913–923
  18. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults, Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) (Adult Treatment Panel III), JAMA 285 (2001) 2486–2497.
  19. International Diabetes Federation, Worldwide definition of the metabolic syndrome, Available at http://www.idf.org/webdata/docs/MetSyndrome_FINAL.pdf (accessed September 4, 2009).
  20. The expert committee on the Diagnosis and Classification of Diabetes Mellitus, Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus, Diabetes Care 26 (s1) (2003) 5–20.
  21. Friedewald WT. Estimation of the concentration of low density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin. Chem. 1972;18:499–502
  22. Rule AD, Larson TS, Bergstralh EJ, Slezak JM, Jacobsen SJ, Cosio FG. Using serum creatinine to estimate glomerular filtration rate: accuracy in good health and in chronic kidney disease. Ann. Intern. Med. 2004;21:929–937
  23. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412–419
  24. Verga S, Buscemi S, Caimi G. Resting energy expenditure and body composition in morbidly obese, obese and control subjects. Acta Diabetol. 1994;31:47–51
  25. Armellini F, Zamboni M, Robbi R, Todesco T, Rigo L, Bergamo-Andreis IA, et al. Total and intra-abdominal fat measurements by ultrasound and computerized tomography. Int. J. Obesity. 1993;17:209–214
  26. Simon A, Gariepy J, Chironi G, Megnien JL, Levenson J. Intima-media thickness: a new tool for diagnosis and treatment of cardiovascular risk. J. Hypertens. 2002;20:159–169
  27. Pontremoli R, Viazzi F, Martinoli C, Ravera M, Nicolella C, Berruti V, et al. Increased renal resistive index in patients with essential hypertension: a marker of target organ damage. Nephrol. Dial. Transplant. 1999;14:360–365
  28. Haffner SM, Lehto S, Rönnemaa T, Pyörälä K, Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N. Engl. J. Med. 1998;339:229–234
  29. Ho JE, Paultre F, Mosca L. Is diabetes mellitus a cardiovascular disease risk equivalent for fatal stroke in women? Data from the Women's Pooling Project. Stroke. 2003;34:2812–2816
  30. Haffner SM, Stern MP, Hazuda HP, Mitchell BD, Patterson JK. Cardiovascular risk factors in confirmed prediabetic individuals. Does the clock for coronary heart disease start ticking before the onset of clinical diabetes?. JAMA. 1990;263:2893–2898
  31. Tedesco MA, Natale F, Mocerino R, Tassinario G, Calabrò R. Renal resistive index and cardiovascular organ damage in a large population of hypertensive patients. J. Hum. Hypertens. 2007;21:291–296
  32. Heine GH, Reichart B, Ulrich C, Köhler H, Girndt M. Do ultrasound renal resistance indices reflect systemic rather than renal vascular damage in chronic kidney disease?. Nephrol. Dial. Transplant. 2007;22:163–170
  33. Heine GH, Gerhart MK, Ulrich C, Köhler H, Girndt M. Renal Doppler resistance indices are associated with systemic atherosclerosis in kidney transplant recipients. Kidney Int. 2005;68:878–885
  34. Campuzano R, Moya JL, García-Liedó A, Tomas JP, Ruiz S, Megías A, et al. Endothelial dysfunction, intima-media thickness and coronary reserve in relation to risk factors and Framingham score in patients without clinical atherosclerosis. J. Hypertens. 2006;24:1581–1588
  35. Patrono C, Fitzgerald GA. Isoprostanes: potential markers of oxidant stress in atherothrombotic disease. Arterioscler. Thromb. Vasc. Biol. 1997;17:2309–2315
  36. Stefan N, Kantartzis K, Machann J, Schick F, Thamer C, Rittig K, et al. Identification and characterization of metabolically benign obesity in humans. Arch. Intern. Med. 2008;168:1607–1616
  37. Kim SK, Kim HJ, Hur KY, Choi SH, Ahn CW, Lim SK, et al. Visceral fat thickness measured by ultrasonography can estimate not only visceral obesity but also risks of cardiovascular and metabolic diseases. Am. J. Clin. Nutr. 2004;79:593–599
  38. Liu KH, Chan YL, Chan WB, Chan JC, Chu CW. Mesenteric fat thickness is an independent determinant of metabolic syndrome and identifies subjects with increased carotid intima-media thickness. Diabetes Care. 2006;29:379–384
  39. Rana JS, Nieuwdorp M, Jukema JW, Kastelein JJP. Cardiovascular metabolic syndrome – an interplay of obesity, inflammation, diabetes and coronary heart disease. Diabetes Obes. Metab. 2007;9:218–232
  40. Hung J, McQuillan BM, Thompson PL, Beilby JP. Circulating adiponectin levels associate with inflammatory markers, insulin resistance and metabolic syndrome independent of obesity. Int. J. Obes. Relat. Metab. Disord. 2008;32:772–779
  41. Cnop M, Havel PJ, Utzschneider KM, Carr DB, Sinha MK, Boyko EJ, et al. Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex. Diabetologia. 2003;46:459–469
  42. Zamchetti A, Hennig M, Baurecht H, Tang R, Cuspidi C, Carugo S, et al. Prevalence and incidence of the metabolic syndrome in the European Lacidipine Study on Atherosclerosis (ELSA) and its relation with carotid intima-media thickness. J. Hypertens. 2007;25:2463–2470
  43. Norata GD, Raselli S, Grigore L, Garlaschelli K, Dozio E, Magni P, et al. Leptin:Adiponectin ratio is an independent predictor of intima media thickness of the common carotid artery. Stroke. 2007;38:2844–2846
  44. Grundy SM. Metabolic syndrome: connecting and reconciling cardiovascular and diabetes worlds. JACC. 2006;47:1093–1100

PII: S0168-8227(09)00407-0

doi: 10.1016/j.diabres.2009.09.015

Diabetes Research and Clinical Practice
Volume 86, Issue 3 , Pages 177-185 , December 2009

Article Tools

* Image Usage & Resolution